Can Optometrists Diagnose And Manage Glaucoma Effectively

Glaucoma remains one of the leading causes of irreversible blindness worldwide, earned largely through its silent, progressive nature. In primary clinical practice, we frequently meet patients who believe that an optometrist only prescribes eyeglasses or contact lenses, while glaucoma treatment requires an immediate visit to an ophthalmic surgeon. Conversely, we also care for individuals who have had elevated intraocular pressure successfully managed by their family optometrist for decades without ever stepping into a surgical suite.

Understanding whether an optometrist can diagnose and manage glaucoma effectively requires evaluating professional training, state scope-of-practice legislation, clinical diagnostic technology, and structured co-management protocols.

Key Takeaways

• Doctors of Optometry (ODs) undergo four years of doctoral-level post-graduate education, equipping them to diagnose, manage, and treat primary open-angle glaucoma, normal-tension glaucoma, and ocular hypertension.
• Primary optometric diagnostic protocols utilize Goldmann applanation tonometry, gonioscopy, corneal pachymetry, spectral-domain optical coherence tomography (SD-OCT), and standard automated perimetry.
• State regulatory boards determine optometric treatment authority; while topical and oral pharmacotherapy is standard across all 50 states, 17 states authorize certified optometrists to perform selective laser trabeculoplasty (SLT) and laser peripheral iridotomy (LPI).
• Incisional surgical interventions, including trabeculectomy, glaucoma drainage implant placement, and complex minimally invasive glaucoma surgery (MIGS), remain the exclusive domain of board-certified ophthalmologists and fellowship-trained glaucoma specialists.
• Collaborative co-management models between primary care optometrists and surgical specialists optimize patient outcomes, preserve visual fields, lower healthcare travel costs, and enhance long-term compliance.

The Expanding Clinical Scope of Optometry in Glaucoma Care

The perception that optometric care is limited to refractive correction is outdated. Modern doctors of optometry complete rigorous clinical education that includes ocular pharmacology, neuro-ophthalmology, systemic disease management, and advanced clinical diagnostics. According to American Optometric Association clinical standards, optometrists serve as the primary entry point for eye care across more than 99 percent of the United States population, placing them on the front lines of early disease detection.

Scope of practice regulations are enacted at the state level, creating variation in the specific therapeutic modalities an optometrist may employ.

• Universal Pharmacologic Authority: Optometrists in all 50 US states and the District of Columbia are licensed to prescribe topical hypotensive agents, including prostaglandin analogs, beta-blockers, alpha-agonists, carbonic anhydrase inhibitors, and rho-kinase inhibitors.
• Oral Medication Privileges: Most state optometry boards authorize ODs to prescribe short-term oral carbonic anhydrase inhibitors (such as acetazolamide) to acutely lower dangerously spiked intraocular pressure.
• In-Office Laser Privileges: Seventeen states—including Virginia, Oklahoma, Kentucky, Louisiana, Arkansas, Colorado, Indiana, Kansas, Tennessee, and Vermont—permit appropriately certified optometrists to perform selective laser trabeculoplasty (SLT) and laser peripheral iridotomy (LPI).
• Surgical Boundaries: Incisional intraocular procedures, operating-room MIGS installations, and filtering surgeries are strictly restricted to medical doctors (MDs) and doctors of osteopathic medicine (DOs) specializing in ophthalmology.

In daily practice, we find that early-stage open-angle glaucoma and ocular hypertension fall squarely within the clinical competence of primary care optometrists. Long-term studies monitored by the National Eye Institute research data emphasize that early pressure reduction prevents optic nerve axon degeneration, a goal effectively achieved in optometric offices.

Comprehensive Glaucoma Diagnostic Workup in Optometric Practice

Accurate glaucoma diagnosis requires evaluating multiple structural and functional metrics rather than relying on a single intraocular pressure (IOP) reading. Optometric clinics are equipped with identical diagnostic technologies used in tertiary academic medical centers.

• Goldmann Applanation Tonometry (GAT): Recognized as the clinical gold standard for measuring intraocular pressure. We utilize applanation rather than screening air-puff tonometry to obtain precise baseline pressure measurements.
• Corneal Pachymetry: Ultrasonically or optically measures central corneal thickness (CCT). Thin corneas (under 520 microns) can cause tonometers to underestimate true IOP, whereas thick corneas (over 580 microns) can artificially elevate readings.
• Gonioscopy: Uses a specialized multi-mirrored lens to directly inspect the iridocorneal drainage angle. This differentiates open-angle glaucoma from narrow-angle or angle-closure variants, pigment dispersion syndrome, and pseudoexfoliation.
• Spectral-Domain Optical Coherence Tomography (SD-OCT): Captures micron-level cross-sectional images of the retinal nerve fiber layer (RNFL) and ganglion cell-inner plexiform layer (GCIPL). SD-OCT identifies structural thinning before functional visual field defects become evident.
• Standard Automated Perimetry (SAP): Measures visual field sensitivity across 24-degree or 10-degree field tests (e.g., Humphrey Visual Field analyzer) to detect subtle paracentral scotomas or nasal steps.

In our clinical experience, subtle presentations require synthesis of these datasets. For example, we evaluated a 62-year-old patient who presented with seemingly benign intraocular pressures of 18 mmHg in both eyes. During baseline SD-OCT imaging, we identified asymmetric neuroretinal rim thinning and localized RNFL loss in the inferior temporal quadrant of the right eye. Corneal pachymetry revealed thin central corneas measuring 490 microns in both eyes.

By factoring in central corneal thickness, we recognized that the true physiological pressure was higher than measured. We performed gonioscopy, confirming open iridocorneal angles with moderate trabecular meshwork pigmentation. We initiated a topical prostaglandin analog at bedtime. Over a three-year follow-up period, sequential SD-OCT visual field trend analyses demonstrated stable nerve fiber thickness and no visual field decay, proving that primary optometric detection and early intervention successfully halted silent progression.

Managing Primary Open-Angle Glaucoma and Ocular Hypertension

Once diagnosed, managing primary open-angle glaucoma involves establishing a target intraocular pressure—typically a 20 to 30 percent reduction from baseline—and maintaining it to prevent optic nerve structural loss.

Optometrists manage pharmacotherapy through a structured approach:

1. First-Line Monotherapy: Initiating therapy with a topical prostaglandin analog (e.g., latanoprost, bimatoprost) or a selective laser trabeculoplasty procedure in states where authorized. Prostaglandins increase uveoscleral outflow and require once-daily dosing, maximizing patient compliance.
2. Efficacy Evaluation: Assessing intraocular pressure response four to six weeks after initiating treatment, while screening for localized side effects such as conjunctival hyperemia or iris hyperpigmentation.
3. Escalation and Fixed Combinations: If target IOP is not achieved, optometrists either switch medication classes or add a secondary agent (e.g., beta-blockers, alpha-2 agonists, or rho-kinase inhibitors like netarsudil). Fixed-combination drops are frequently selected to reduce daily drop burden and eliminate preservative washout.
4. Functional and Structural Surveillance: Scheduling pressure checks every three to six months, with annual visual field perimetry and SD-OCT nerve scans to confirm structural stability.

When systemic health co-morbidities arise, optometric management requires clinical adaptation. We managed a 71-year-old chronic open-angle glaucoma patient whose intraocular pressure drifted upward to 24 mmHg on latanoprost monotherapy. Adding a topically applied beta-blocker (timolol) appeared logically sound, but a review of the patient’s medical history revealed moderate asthma and sinus bradycardia. Prescribing a non-selective beta-blocker could have triggered bronchospasm or worsened bradycardia.

Instead, we prescribed a topical carbonic anhydrase inhibitor/alpha-agonist combination drop (brinzolamide/brimonidine), which lowered intraocular pressure down to a safe target of 15 mmHg without compromising cardiorespiratory stability.

Surgical Thresholds and Specialist Referral Triggers

While optometrists manage the majority of mild-to-moderate primary open-angle glaucoma cases, clear clinical parameters dictate when care must be transferred or co-managed with a fellowship-trained glaucoma specialist or corneal surgeon.

According to American Academy of Ophthalmology preferred practice patterns, complex disease states demand tertiary surgical consultation. Key triggers for specialist referral include:

• Uncontrolled Intraocular Pressure: Intraocular pressure remains above target despite maximal tolerated medical therapy (typically three or four pharmacologic agents).
• Rapid Disease Progression: Visual field perimetry or SD-OCT demonstrates active, progressive axonal loss over consecutive visits regardless of measured IOP.
• Acute Angle-Closure Glaucoma: Sudden severe IOP spikes accompanied by corneal edema, mid-dilated fixed pupil, nausea, and severe ocular pain require emergency pressure lowering followed by immediate surgical iridotomy.
• Complex Secondary Glaucomas: Neovascular glaucoma secondary to diabetic retinopathy or retinal vein occlusion, uveitic glaucoma, and developmental/pediatric glaucomas.
• Advanced Disease at Presentation: Patients presenting with cup-to-disc ratios exceeding 0.85, central visual field loss threatening fixation, or severe loss of tubular visual field.
• Surgical Candidacy: Patients requiring advanced procedural interventions such as trabeculectomy, Ahmed or Baerveldt tube shunt implantation, or combination cataract extraction with MIGS devices (e.g., iStent, Hydrus microstent).

Comparative Analysis of Primary Care vs. Surgical Specialist Management

Selecting between ongoing primary optometric care, co-management, or direct glaucoma specialist care depends on disease severity, geographic proximity, and procedure requirements.

Collaborative Co-Management Protocols and Complex Case Outcomes

The most efficient healthcare delivery system combines the localized accessibility of primary optometrists with the advanced surgical expertise of ophthalmologists. Co-management ensures that patients receive frequent, local monitoring while maintaining rapid access to surgical suites when medical therapy falters.

Consider a complex case we co-managed involving a 58-year-old patient who presented to our optometric practice with narrow iridocorneal angles (Van Herick Grade 1) during a routine vision exam. Gonioscopy confirmed iridocorneal contact across 270 degrees without peripheral anterior synechiae (PAS). The patient was asymptomatic, but intraocular pressure measured 26 mmHg in the right eye and 28 mmHg in the left eye.

We immediately initiated topical apraclonidine and pilocarpine to pull the peripheral iris away from the trabecular meshwork and referred the patient urgently to a local ophthalmic surgeon. The specialist performed bilateral neodymium-doped yttrium-aluminum-garnet (Nd:YAG) laser peripheral iridotomies (LPI) to relieve pupillary block. Following the laser procedure, the patient was transferred back to our optometric clinic for post-operative recovery monitoring and long-term IOP tracking.

Over five years of co-managed follow-up, intraocular pressures stabilized at 14 mmHg without drops, and the patient avoided invasive incisional surgery through timely interprofessional intervention.

Frequently Asked Questions

Can an optometrist diagnose glaucoma during a routine eye exam?

Yes. Optometrists diagnose glaucoma during routine exams by combining Goldmann applanation tonometry, gonioscopy, optical coherence tomography (OCT) of the optic nerve, corneal pachymetry, and automated visual field testing. Glaucoma is often asymptomatic in early stages, making routine optometric examinations essential for early detection.

What medications can optometrists prescribe for glaucoma management?

Optometrists in all 50 US states are licensed to prescribe topical therapeutic agents, including prostaglandin analogs, beta-blockers, alpha-agonists, carbonic anhydrase inhibitors, and rho-kinase inhibitors. In most jurisdictions, optometrists can also prescribe short-term oral carbonic anhydrase inhibitors to manage acute intraocular pressure elevations.

Can optometrists perform laser treatments or surgery for glaucoma?

Optometrists do not perform incisional intraocular surgeries, such as trabeculectomies or glaucoma drainage implant procedures. However, an increasing number of states—including Virginia, Oklahoma, Kentucky, Louisiana, Kansas, Tennessee, Vermont, and Colorado—authorize certified optometrists to perform specific office-based laser procedures, including selective laser trabeculoplasty (SLT) and laser peripheral iridotomy (LPI).

How often should a glaucoma patient see their optometrist for monitoring?

Stable glaucoma patients typically visit their optometrist every three to six months for intraocular pressure checks and optic nerve head evaluation. Comprehensive visual field testing and structural SD-OCT scans are generally repeated every 6 to 12 months to ensure disease stability.

When is it necessary to see a fellowship-trained glaucoma specialist?

Consulting a fellowship-trained glaucoma specialist becomes necessary when intraocular pressure remains uncontrolled despite maximal medical therapy, when visual field loss progresses rapidly, in cases of acute angle-closure or secondary glaucomas, or when surgical interventions like MIGS, trabeculectomy, or tube shunts are required.

Sources

1. American Optometric Association. Optometric Scope of Practice and Clinical Practice Guidelines. https://www.aoa.org/healthy-eyes/eye-and-vision-conditions/glaucoma
2. American Academy of Ophthalmology. Preferred Practice Pattern: Primary Open-Angle Glaucoma. https://www.aao.org/eye-health/diseases/what-is-glaucoma
3. National Eye Institute. Glaucoma Data and Health Information. https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/glaucoma
4. Eyes On Eyecare. Optometry Scope of Practice in the United States Guide. https://eyesoneyecare.com/resources/optometry-scope-of-practice-united-states/
5. Review of Optometry. State Scope Expansion and Laser Privileges Updates. https://www.reviewofoptometry.com/article/optometric-scope-breaking-down-barriers